<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00486447</url>
  </required_header>
  <id_info>
    <org_study_id>GE-189-03</org_study_id>
    <nct_id>NCT00486447</nct_id>
  </id_info>
  <brief_title>Perfusion Imaging and CT -Understanding Relative Efficacy</brief_title>
  <acronym>PICTURE</acronym>
  <official_title>A Prospective Multi-center Study Comparing Cardiac Computed Tomography (CT) Using a 64-detector Row Volumetric Computed Tomography (VCT) Scanner for the Detection of Coronary Artery Disease With Cardiac Radionuclide Imaging.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the relative efficacy of Cardiac Computed Tomography Angiography (CCTA) and&#xD;
      Single Positron Emission Computed Tomography (SPECT) in patients with an intermediate risk of&#xD;
      CAD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, multi-center, within-subject comparative study. One hundred&#xD;
      fifty (150) subjects with CATH procedures are needed in the study. Approximately 300 subjects&#xD;
      who meet all of the inclusion/exclusion criteria will be enrolled. The study population will&#xD;
      consist of subjects with symptoms suspected of and at intermediate-risk for ischemic heart&#xD;
      disease, which are referred for MPS for a definitive diagnosis of CAD.&#xD;
&#xD;
      Each subject will undergo the following procedures:&#xD;
&#xD;
        -  A Myocardial Perfusion Study (MPS) procedure, as standard of care;&#xD;
&#xD;
        -  An IV contrast-enhanced cardiac CT (CCTA) procedure;&#xD;
&#xD;
        -  A CATH procedure when the MPS and/or cardiac CT examination is deemed positive or&#xD;
           equivocal and at the discretion of the referring physicians, as a standard-of-care&#xD;
           procedure.&#xD;
&#xD;
      When both the MPS and CCTA are normal, the subject is not required to undergo a CATH&#xD;
      procedure, but will enter into follow-up. The research staff at each site will perform&#xD;
      follow-up for each subject at 12 months (± 15 days) and 24 months (± 15 days) and 36 months&#xD;
      (± 15 days) after the completion of the cardiac CT procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Accrual&#xD;
  </why_stopped>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of Significant Coronary Artery Disease Using Diagnostic Catheterization for Standard of Truth.</measure>
    <time_frame>through study completion, an expected average of 1 year</time_frame>
    <description>Number of subjects with CT for detection purposes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Outcomes - EKG, Laboratory Workup, Changes in Medical Management, Downstream Cardiac Testing, Significant Coronary Interventions, and Major Cardiac Events &amp; Long-term Outcomes (Non-fatal MI and Cardiac-related Death).</measure>
    <time_frame>1 year outcomes after initial MPS exam</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">249</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Imaging</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General imaging subjects receiving CT exams</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>64 Channel VCT</intervention_name>
    <description>cardiac CT angiography exam</description>
    <arm_group_label>Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with an intermediate probability risk for coronary artery disease.&#xD;
&#xD;
          -  Subject has symptoms of suspected ischemic heart disease.&#xD;
&#xD;
          -  Subject is at intermediate risk for coronary artery disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The subject has undergone a prior CCTA within 6 months prior to entering the study.&#xD;
&#xD;
          -  The subject has a documented history of CAD by CATH, myocardial infarction (MI), metal&#xD;
             stent placement in any of the coronary vessels, or a previous coronary artery bypass&#xD;
             graft (CABG) procedure&#xD;
&#xD;
          -  The subject has hemodynamic or active clinical instability:&#xD;
&#xD;
               -  Acute chest pain (sudden onset);&#xD;
&#xD;
               -  Cardiac shock;&#xD;
&#xD;
               -  Unstable blood pressure (BP);&#xD;
&#xD;
               -  Severe congestive heart failure or acute pulmonary edema.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Budoff</last_name>
    <role>Study Chair</role>
    <affiliation>LA Biomedical Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GE Healthcare</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>June 12, 2007</study_first_submitted>
  <study_first_submitted_qc>June 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2007</study_first_posted>
  <results_first_submitted>May 3, 2017</results_first_submitted>
  <results_first_submitted_qc>July 24, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 23, 2017</results_first_posted>
  <last_update_submitted>July 24, 2017</last_update_submitted>
  <last_update_submitted_qc>July 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Imaging</title>
          <description>Enrolled subjects for general imaging</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="249"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="249"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects</population>
      <group_list>
        <group group_id="B1">
          <title>Imaging</title>
          <description>General imaging subjects receiving CT exams&#xD;
64 Channel VCT: cardiac CT angiography exam</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="249"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="249"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30" lower_limit="18" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Gender was not record for analysis for this study.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Detection of Significant Coronary Artery Disease Using Diagnostic Catheterization for Standard of Truth.</title>
        <description>Number of subjects with CT for detection purposes</description>
        <time_frame>through study completion, an expected average of 1 year</time_frame>
        <population>Data were not collected for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Enrolled</title>
            <description>Enrolled subjects for general imaging</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Significant Coronary Artery Disease Using Diagnostic Catheterization for Standard of Truth.</title>
          <description>Number of subjects with CT for detection purposes</description>
          <population>Data were not collected for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Outcomes - EKG, Laboratory Workup, Changes in Medical Management, Downstream Cardiac Testing, Significant Coronary Interventions, and Major Cardiac Events &amp; Long-term Outcomes (Non-fatal MI and Cardiac-related Death).</title>
        <time_frame>1 year outcomes after initial MPS exam</time_frame>
        <population>Data were not collected for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Outcome Measure 2</title>
            <description>1 year clinical outcome follow-up (Study terminated prior to collection)</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Outcomes - EKG, Laboratory Workup, Changes in Medical Management, Downstream Cardiac Testing, Significant Coronary Interventions, and Major Cardiac Events &amp; Long-term Outcomes (Non-fatal MI and Cardiac-related Death).</title>
          <population>Data were not collected for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Enrolled</title>
          <description>Subjects receiving diagnostic CT scans</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="249"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="249"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Angela N. Johnson, Senior Manager Clinical Affairs Operations</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>262-226-9495</phone>
      <email>angela.johnson@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

